Latest return on equity
Cardiol Therapeutics Return on equity
Cardiol Therapeutics (CRDL) return on equity with its verified observation date.
Direct answer
Cardiol Therapeutics's return on equity is -190.18%.
The verified market snapshot reports -190.18%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 28, 2026.
Get free Cardiol Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -190.18%
Explore related company data
View Cardiol Therapeutics's market capitalizationView Cardiol Therapeutics's price-to-book ratioView Cardiol Therapeutics's 52-week price rangeView Cardiol Therapeutics's profit marginView Cardiol Therapeutics's debt-to-equity ratioView all Cardiol Therapeutics key metricsReturn to Cardiol Therapeutics profile